What is the mechanism of action of bimekizumab and how does it differ from other systemic psoriasis treatments?

Featuring Mark Lebwohl, MD | Senior Clinical Advisor |

Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics at the Icahn School of Medicine, Mount Sinai
New York, NY

| Published November 06, 2023

Loading...

Related CME

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2025 dermsquared | All Rights Reserved